Lupin set to launch generic of seizure drug in U.S.
Lupin set to launch generic of seizure drug in U.S. is drawing significant interest across the industry.
Drugmaker Lupin on Wednesday said it has initiated launch of Brivaracetam Oral Solution 10 mg/mL in the United States following U.S. Food and Drug Administration (U.S. FDA) approval for its abbreviated new drug application.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Govt sets up 17-member committee for larger reforms in SEZ policy
- Thales to Bolster Engineering Workforce in India
- Trump Launches ‘Task Force Scorpion’ as Iran Peace Talks Collapse
- London Fashion Week 2026: the key trends and styles
Source: Original →